1. (a) End stage renal dialysis centers shall, when submitting ESRD data, report intravenous antimicrobial administration by complying with the United States Centers for Disease Control and Prevention, National Healthcare Safety Network, “End Stage Renal Dialysis (ESRD) Event” protocol (January 2022 edition), available as noted in Appendix A at http://www.cdc.gov/nhsn/pdfs/pscmanual/8pscdialysiseventcurrent.pdf.

2. (b) In addition to the reporting requirements identified in (a) above, end stage renal dialysis centers shall submit ESRD data within 60 days of the close of each quarter, as follows:

   1. (1) Quarter 1 data, from January 1st to March 31st, shall be reported on or before May 30th;
   2. (2) Quarter 2 data, from April 1st to June 30th, shall be reported on or before August 29th;
   3. (3) Quarter 3 data, from July 1st to September 30th, shall be reported on or before November 29th; and
   4. (4) Quarter 4 data, from October 1st to December 31st, shall be reported on or before March 1st of the following calendar year.

3. (c) Ambulatory surgical centers shall report the list of procedures during which the patient received intravenous prophylactic antibiotic to the department on the “Intravenous Antibiotic Reporting Form” (November 2019) within 60 days of the close of each quarter, as follows:

   1. (1) Quarter 1 data, from January 1st to March 31st, shall be reported on or before May 30th;
   2. (2) Quarter 2 data, from April 1st to June 30th, shall be reported on or before August 29th;
   3. (3) Quarter 3 data, from July 1st to September 30th, shall be reported on or before November 29th; and
   4. (4) Quarter 4 data, from October 1st to December 31st, shall be reported on or before March 1st of the following calendar year.
4. (d) The department shall contact all ambulatory surgery centers via email no later than March 15 of each year, and provide the survey, as well as a pdf copy.

5. (e) Ambulatory surgery centers shall either:

   1. (1) Complete the survey; or

   2. (2) Complete the pdf version of the survey and return to the department via:

      1. a. Email, as an email attachment, to haiprogram@dhhs.nh.gov;
      2. b. Fax, at (603) 271-0545; or

      3. c. Mail, to:

         Healthcare Associated Infections Surveillance Program

         Bureau of Disease Control

         Division of Public Health Services

         Department of Health and Human Services

         29 Hazen Drive

         Concord, NH 03301

6. (f) Ambulatory surgery centers shall report the following measures on the “Intravenous Antibiotic Reporting Form” (November 2019):

   1. (1) Facility name;
   2. (2) Unique patient identification number;
   3. (3) Date of the surgery or procedure;
   4. (4) Type of procedure using codes as defined by the World Health Organization’s “International Classification of Diseases (ICD)” (11th Revision), available as noted in Appendix B;
   5. (5) Type of prophylactic antibiotic;
   6. (6) Time of the start of the intravenous antibiotic was included; and
   7. (7) Time of the start of the incision.
7. (g) Specialty hospitals shall not be required to report surgical antimicrobial prophylaxis data and intravenous antimicrobial administration.
8. (h) Residential care facilities, assisted living residences, nursing homes, and the veterans’ home shall not be required to report surgical antimicrobial prophylaxis data and intravenous antimicrobial administration.

Source. #9851, eff 1-14-11; amd by #10079, eff 1-26-12 (from He-P 309.06); ss by #12943, eff 12-11-19 (formerly He-P 309.07); renumbered by #13282, INTERIM (formerly He-P 309.11); ss by #13351, eff 3-19-22 (see Revision Note at part heading for He-P 309)